Avience Biomedicals (NSE:AVIENCE) Total Receivables: ₹198.7 Mil (As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals Total Receivables?

Avience Biomedicals NSE:AVIENCE 5 Total Receivables is ₹198.7 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Avience Biomedicals's Total Receivables for the quarter that ended in Jan. 2026 was ₹198.7 Mil.

Avience Biomedicals Total Receivables Related Terms

Avience Biomedicals Total Receivables Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Total Receivables Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Total Receivables
30.86 84.10 176.12

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
Total Receivables 30.86 84.10 176.12 198.68
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹198.7 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a Total Receivables of ₹198.7 Mil as of Jan. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' Total Receivables too high?
Avience Biomedicals' current Total Receivables is ₹198.7 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Total Receivables compare to ABT and SYK?
Avience Biomedicals' Total Receivables of ₹198.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Devices & Instruments company?
A good Total Receivables depends on the Medical Devices & Instruments industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current Total Receivables is ₹198.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Total Receivables of ₹198.7 Mil. The current Total Receivables is ₹198.7 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Total Receivables is ₹198.7 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price